Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the 29
causative pathogen of Coronavirus disease 2019 (COVID-19), has resulted in over 650 30 …

The issue of bacterial infections in COVID-19 patients has received increasing attention
among scientists. Antibiotics were widely prescribed during the early phase of the pandemic …

Background Recent single-center reports have suggested that community-acquired
bacteremic co-infection in the context of Coronavirus disease 2019 (COVID-19) may be an …

Respiratory virus infection can cause severe illnesses capable of inducing acute respiratory
failure that can progress rapidly to acute respiratory distress syndrome (ARDS). ARDS is …

Background There were a few studies on bacterial coinfection in hospitalized COVID-19
patients worldwide. This systematic review aimed to provide the pooled prevalence of …

Background Most people are infected with COVID-19 during pandemics at the end of 2022.
Older patients were more vulnerable. However, the incidence of secondary bacterial, fungal …

Background Similar to influenza, coinfections and superinfections are common and might
result in poor prognosis. Our study aimed to compare the characteristics and risks of …

Accurate characterization of respiratory bacterial co-infection is critical for guiding empirical
antibiotic treatment for hospitalised patients with coronavirus disease 2019 (COVID-19). We …

Acute respiratory infections (ARIs) are a major cause of morbidity and mortality among
children. The causative pathogens show geographic and seasonal variations. We …

Background Metagenomic next-generation sequencing (mNGS) is a promising tool for
improving antimicrobial therapy and infection control decision-making in complex infections …